EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series

Larissa Leandro Medeiros, Thales Queiroz Souza, Maria Luiza Cronemberger de Faria, Ricardo Jacarandá de Faria, Zuleica Barrio Bortoli, Ana Carolina Benvindo Lopes, Bruno Augusto Alves Martins, Marcos De Vasconcelos Carneiro, Caio Cardozo Jorge

Revista de Gastroenterología del Perú · 29.03.2026 · 46 (1) · 14-19

DOI: 10.47892/rgp.2026.461.2047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista de Gastroenterología del Perú, online erschienen am 29.03.2026. Verfasst von Larissa Leandro Medeiros und 8 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To report a case series of patients with inflammatory bowel diseases and a history of malignancy and to analyze how this condition influenced therapeutic decisionmaking presents a challenging scenario. Materials and methods: This was a retrospective observational study analyzing 11 patients with inflammatory bowel disease and malignant neoplasms followed at an inflammatory bowel disease outpatient clinic of a university hospital. Clinical, therapeutic, and oncologic findings are reported descriptively based on medical record review.

Results

Seven patients (64%) had ulcerative colitis, and six (55%) were female, with a mean age of 47 years. Extra-intestinal neoplasms predominated. Six patients (55%) received advanced therapy near the time of cancer diagnosis; reintroduction was possible in four cases. Judicial action was required for two patients.

Conclusions

Clinical decision-making in patients with inflammatory bowel disease and a history of malignancy is an individualized process, based on multidisciplinary discussion, bioethical considerations, and the most reliable available evidence, even in the face of state-imposed logistical obstacles. Continuous updating of Clinical Protocols and Therapeutic Guidelines is essential to ensure equitable access to the most appropriate and non-harmful treatment for this patient group.

Zitieren

APA

Medeiros, L. L., Souza, T. Q., Faria, M. L. C. D., Faria, R. J. D., Bortoli, Z. B., Lopes, A. C. B., Martins, B. A. A., Carneiro, M. D. V., & Jorge, C. C. (2026). Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series. Revista de Gastroenterología del Perú, 46(1), 14-19. https://doi.org/10.47892/rgp.2026.461.2047

Vancouver

Medeiros LL, Souza TQ, Faria MLCD, Faria RJD, Bortoli ZB, Lopes ACB, et al. Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series. Revista de Gastroenterología del Perú. 2026;46(1):14-19. doi:10.47892/rgp.2026.461.2047

BibTeX
@article{Medeiros2026,
  author = {Medeiros, Larissa Leandro and Souza, Thales Queiroz and Faria, Maria Luiza Cronemberger de and Faria, Ricardo Jacarandá de and Bortoli, Zuleica Barrio and Lopes, Ana Carolina Benvindo and Martins, Bruno Augusto Alves and Carneiro, Marcos De Vasconcelos and Jorge, Caio Cardozo},
  title = {Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series},
  journal = {Revista de Gastroenterología del Perú},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {14--19},
  doi = {10.47892/rgp.2026.461.2047}
}
Kostenlos starten →